195 related articles for article (PubMed ID: 27889884)
1. Reduced density gradient as a novel approach for estimating QSAR descriptors, and its application to 1, 4-dihydropyridine derivatives with potential antihypertensive effects.
Jardínez C; Vela A; Cruz-Borbolla J; Alvarez-Mendez RJ; Alvarado-Rodríguez JG
J Mol Model; 2016 Dec; 22(12):296. PubMed ID: 27889884
[TBL] [Abstract][Full Text] [Related]
2. Docking and QSAR Studies of 1,4-Dihydropyridine Derivatives as Anti- Cancer Agent.
Mollazadeh S; Shamsara J; Iman M; Hadizadeh F
Recent Pat Anticancer Drug Discov; 2017; 12(2):174-185. PubMed ID: 28137213
[TBL] [Abstract][Full Text] [Related]
3. Quantitative structure-activity relationship for cyclic imide derivatives of protoporphyrinogen oxidase inhibitors: a study of quantum chemical descriptors from density functional theory.
Wan J; Zhang L; Yang G; Zhan CG
J Chem Inf Comput Sci; 2004; 44(6):2099-105. PubMed ID: 15554680
[TBL] [Abstract][Full Text] [Related]
4. Discovery of Potent Antihypertensive Ligands Substituted Imidazolyl Biphenyl Sulfonylureas Analogs as Angiotensin II AT1 Receptor Antagonists by Molecular Modelling Studies.
Sharma MC
Interdiscip Sci; 2015 Sep; 7(3):221-32. PubMed ID: 26188391
[TBL] [Abstract][Full Text] [Related]
5. QSAR study of imidazoline antihypertensive drugs.
Nikolic K; Filipic S; Agbaba D
Bioorg Med Chem; 2008 Aug; 16(15):7134-40. PubMed ID: 18621536
[TBL] [Abstract][Full Text] [Related]
6. Quantitative structure-activity relationship and quantitative structure-pharmacokinetics relationship of 1,4-dihydropyridines and pyridines as multidrug resistance modulators.
Zhou XF; Shao Q; Coburn RA; Morris ME
Pharm Res; 2005 Dec; 22(12):1989-96. PubMed ID: 16158213
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity study of antihypertensive 1,4-dihydropyridine derivatives having nitrooxyalkyl moieties at the 3 and 5 positions.
Kawashima Y; Ogawa T; Kato M; Nakazato A; Tsuchida K; Hatayama K; Hirono S; Moriguchi I
Chem Pharm Bull (Tokyo); 1993 Jun; 41(6):1060-5. PubMed ID: 8370106
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and 3D-QSAR studies of novel 1,4-dihydropyridines as TGFβ/Smad inhibitors.
Längle D; Marquardt V; Heider E; Vigante B; Duburs G; Luntena I; Flötgen D; Golz C; Strohmann C; Koch O; Schade D
Eur J Med Chem; 2015 May; 95():249-66. PubMed ID: 25817775
[TBL] [Abstract][Full Text] [Related]
9. QSAR and classification study of 1,4-dihydropyridine calcium channel antagonists based on least squares support vector machines.
Yao X; Liu H; Zhang R; Liu M; Hu Z; Panaye A; Doucet JP; Fan B
Mol Pharm; 2005; 2(5):348-56. PubMed ID: 16196487
[TBL] [Abstract][Full Text] [Related]
10. Comparison of a neural net-based QSAR algorithm (PCANN) with Hologram- and multiple linear regression-based QSAR approaches: application to 1,4-dihydropyridine-based calcium channel antagonists.
Viswanadhan VN; Mueller GA; Basak SC; Weinstein JN
J Chem Inf Comput Sci; 2001; 41(3):505-11. PubMed ID: 11410024
[TBL] [Abstract][Full Text] [Related]
11. Hybrid Docking-QSAR Studies of 1, 4-dihydropyridine-3, 5-Dicarboxamides as Potential Antitubercular Agents.
Rasouli Y; Davood A
Curr Comput Aided Drug Des; 2018; 14(1):35-53. PubMed ID: 28462696
[TBL] [Abstract][Full Text] [Related]
12. Development of a general quantum-chemical descriptor for steric effects: density functional theory based QSAR study of herbicidal sulfonylurea analogues.
Xi Z; Yu Z; Niu C; Ban S; Yang G
J Comput Chem; 2006 Oct; 27(13):1571-6. PubMed ID: 16868987
[TBL] [Abstract][Full Text] [Related]
13. A new computational model for the prediction of toxicity of phosphonate derivatives using QSPR.
Camacho-Mendoza RL; Aquino-Torres E; Cordero-Pensado V; Cruz-Borbolla J; Alvarado-Rodríguez JG; Thangarasu P; Gómez-Castro CZ
Mol Divers; 2018 May; 22(2):269-280. PubMed ID: 29532429
[TBL] [Abstract][Full Text] [Related]
14. Modeling calcium channel antagonistic activity of dihydropyridine derivatives using QTMS indices analyzed by GA-PLS and PC-GA-PLS.
Mohajeri A; Hemmateenejad B; Mehdipour A; Miri R
J Mol Graph Model; 2008 Apr; 26(7):1057-65. PubMed ID: 17959402
[TBL] [Abstract][Full Text] [Related]
15. Effects of 1,4-dihydropyridine derivatives on cell injury and mTOR of HepG2 and 3D-QSAR study.
Liu H; Zhu S; Xia G; Huang Z; Han W; Li Z; Liu C
Comput Biol Chem; 2024 Apr; 109():108010. PubMed ID: 38232515
[TBL] [Abstract][Full Text] [Related]
16. Dihydropyridine derivatives to overcome atypical multidrug resistance: design, synthesis, QSAR studies, and evaluation of their cytotoxic and pharmacological activities.
Mehdipour AR; Javidnia K; Hemmateenejad B; Amirghofran Z; Miri R
Chem Biol Drug Des; 2007 Oct; 70(4):337-46. PubMed ID: 17937779
[TBL] [Abstract][Full Text] [Related]
17. Comparative QSAR studies of two series of 1,4-dihydropyridines as slow calcium channel blockers.
Wikel JH; Bemis KG; Kurz K; Denney ML; Main BW; Moore RA; Smith T; Shingleton L; Holland DR
Drug Des Discov; 1994 Jan; 11(1):1-14. PubMed ID: 8068815
[TBL] [Abstract][Full Text] [Related]
18. QSAR study of 1,4-dihydropyridine calcium channel antagonists based on gene expression programming.
Si HZ; Wang T; Zhang KJ; Hu ZD; Fan BT
Bioorg Med Chem; 2006 Jul; 14(14):4834-41. PubMed ID: 16580211
[TBL] [Abstract][Full Text] [Related]
19. Different effects of dihydropyridine calcium channel antagonists on CYP3A4 enzyme of human liver microsomes.
Xia Z; Wang M; Zou S; Chen R
Eur J Drug Metab Pharmacokinet; 2012 Sep; 37(3):211-6. PubMed ID: 22161476
[TBL] [Abstract][Full Text] [Related]
20. Impact of geometry optimization methods on QSAR modelling: A case study for predicting human serum albumin binding affinity.
Önlü S; Türker Saçan M
SAR QSAR Environ Res; 2017 Jun; 28(6):491-509. PubMed ID: 28705017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
